Recent research reveals alarming levels of per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” present in fetal blood, significantly exceeding previous estimates. A comprehensive study conducted by Mount Sinai researchers examined umbilical cord blood samples and identified 42 distinct PFAS compounds, suggesting that fetuses are exposed to far more of these harmful chemicals than previously recognised.
Groundbreaking Findings in Fetal Exposure
The study, which involved testing 120 umbilical cord blood samples, employed a novel non-targeted analysis method. This approach allowed researchers to discover a wider array of PFAS compounds than traditional methods, which typically focus on a limited selection, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). Previous analyses had only identified up to four PFAS in individual samples.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study, emphasised the significance of these findings, stating, “Babies are exposed to many more PFAS than we previously thought. It is particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
The Dangers of PFAS
PFAS are a vast class of approximately 15,000 synthetic chemicals widely used for their water-, stain-, and grease-resistant properties. These substances have been linked to numerous health issues, including cancer, birth defects, immune system impairments, elevated cholesterol levels, and kidney disease. Dubbed “forever chemicals,” they resist natural breakdown in the environment, raising concerns about their long-lasting presence in ecosystems and human bodies alike.
Research indicates that elevated maternal PFAS levels correlate with increased infant mortality rates, low birth weights, and higher risks of obesity in later life. Furthermore, fetal exposure to these compounds has been associated with serious long-term health conditions, including various cancers and cardiovascular diseases.
Regulatory Oversight Falling Behind
Despite the known hazards of legacy PFAS compounds like PFOA and PFOS, which have largely been phased out over the past decade, the chemical industry has introduced newer PFAS variants, often claiming they are less toxic. However, there is scant evidence to support these assertions, and new compounds may degrade into different, potentially harmful substances once they enter the environment or human physiology.
The methods employed by regulatory agencies, such as the US Environmental Protection Agency (EPA), have struggled to keep pace with the evolving landscape of PFAS chemistry. Current testing methods typically focus on only 30 to 40 compounds, while independent studies have detected thousands in various environments. A 2022 analysis highlighted the frequent underestimation of PFAS levels in water by regulatory bodies, raising questions about public safety.
The Mount Sinai study effectively juxtaposed traditional analysis with the more expansive non-targeted method, revealing a stark contrast in detection capabilities. While the EPA has recently approved a blood test for 53 PFAS compounds, Liu pointed out that their research uncovered 31 compounds absent from the EPA’s list, underscoring the need for improved regulatory measures.
The Path Forward
Although the study did not directly investigate health consequences, Liu noted that higher PFAS levels are generally linked to increased health risks. The blood samples analysed were part of the federal government’s Home study, which tracks individuals’ PFAS exposure and related health outcomes over time. Researchers at Mount Sinai aim to further explore the health implications of these findings.
David Andrews, acting chief science officer at the Environmental Working Group, a non-profit organisation not involved in the study, remarked, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The implications of these findings are profound, highlighting a critical public health concern regarding chemical exposure in utero. As researchers work to better understand the full extent of PFAS exposure and its potential health repercussions, it becomes increasingly evident that robust regulatory frameworks are essential to safeguard future generations from these pervasive, hazardous substances. The study serves as a clarion call for urgent action to protect vulnerable populations, particularly unborn children, from the dangers posed by forever chemicals.
